The Latvian Medicines Verification Organisation (LZVO) reminds users of the Latvian Medicines Verification System (LZVS) that, in situations when the system reports an L5-level alert, they must follow the European Medicines Verification Organisation (EMVO) guidelines for alert investigation.
Currently, LZVO has no plans to implement Alert Management System (AMS) tools that are used in some other countries.
The EMVO Alert Investigation Guidelines are available here.
Frequently asked questions about alerts, system notifications, and how to proceed in the event of an alert have been compiled on the LZVO website: www.lzvo.lv
- System notifications and alerts (L5 level errors):
System notifications and alerts - LZVO
For any further questions or clarifications, please contact an LZVO representative by writing to: helpdesk@lzvo.lv